tiprankstipranks
TipRanksTop Financial ExpertsInsidersJohn Johnson

John Johnson Insider Profile

4 Followers
John Johnson, Director at AxoGen, holds 14.15K shares in AxoGen (Ticker: AXGN), holds 707.28K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 52.67K shares in Verastem (Ticker: VSTM).
See the Hottest Stocks Based on Insider Trading >
tipranks
John Johnson

John Johnson
AxoGen (AXGN)
Director

Ranked #88,190 out of 108,921 Corporate Insiders

Profitable Transactions

17%
1 out of 6 Profitable Transactions

Average Return

-20.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$7M
84.40%
9.56%
6.04%
0.00%
0.00% Others
A breakdown of John Johnson's holdings
See the Top Stocks by Insiders

Insider Roles

Xeris Pharmaceuticals
(XERS)
Director
AxoGen
(AXGN)
Director
Verastem
(VSTM)
Director
Ocugen
(OCGN)
Director
+1 other positions
Roles that John Johnson holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Melinta Therapeutics
(MLNTQ)
Rating:Informative Buy
Date:May 28, 2014 - May 28, 2015
Return:+297.50%
The most profitable trade made by John Johnson
See the Latest Stocks Traded by Insiders

John Johnson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AXGN
AxoGen
Jun 23, 2026
Director
Uninformative Buy
634.49K
$683.16K
XERS
Xeris Pharmaceuticals
Jun 05, 2026
Director
Uninformative Buy
―
$6.03M
APLT
Applied Therapeutics
Dec 20, 2024
―
Uninformative Buy
―
$51.50K
MLNTQ
Melinta Therapeutics
Jul 02, 2019
―
Informative Sell
72.41K
$4.11K
AVEO
AVEO Pharma
―
―
―
―
SBBP
Strongbridge Biopharma
Oct 05, 2021
―
Uninformative Sell
689.83K
$1.22M
VSTM
Verastem
May 26, 2026
Director
Uninformative Buy
―
$431.86K
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
―
Uninformative Sell
92.34K
$0.00
PTLA
Portola Pharma
Jul 02, 2020
―
Uninformative Sell
131.06K
$0.00
OCGN
Ocugen
―
Director
―
$0.00
DNDNQ
Dendreon Corp
Jul 08, 2014
―
Uninformative Sell
27.69K
―
LLY
Eli Lilly & Co
―
Sr. VP, Oncology Business Unit
―
$0.00
SVNTQ
Savient Pharmaceuticals
Feb 02, 2011
―
Uninformative Buy
―
―
OCRX
Ocera Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see John Johnson's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

John Johnson insider profile FAQ

What is the percentage of profitable transactions made by John Johnson?
The percentage of profitable transactions made by John Johnson is 17%.
    What is the average return per transaction made by John Johnson?
    The average return per transaction made by John Johnson is -20.40%.
      What stocks does John Johnson hold?
      John Johnson holds: AXGN, XERS, APLT, MLNTQ, AVEO, SBBP, VSTM, SCMP, PTLA, OCGN, DNDNQ, LLY, SVNTQ, OCRX stocks.
        What was John Johnson’s latest transaction?
        John Johnson latest transaction was an Uninformative Buy of $634.49K.
          What was John Johnson's most profitable transaction?
          John Johnson’s most profitable transaction was an Informative Buy of MLNTQ stock on May 28, 2014. The return on the trade was 297.50%.
            What is John Johnson's role in AxoGen?
            John Johnson's role in AxoGen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.